Nottingham cancer detection firm lands £1.1m Iranian deal
Nottingham cancer detection company Oncimmune has signed an exclusive agreement for distribution of its EarlyCDT®-Lung test in Iran with Tarvand Sina Tajhiz Co., an Iranian provider of test services and kits to the medical community.
The agreement allows for the sale of the CE marked EarlyCDT®-Lung kit as a screening test and for the risk assessment of indeterminate pulmonary nodules. The agreement is for an initial term of three years and includes minimum sales commitments of £1.1m over the term of the contract. First sales are... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
